Alagebrium cardiovascular data

In a U.S. trial in 13 elderly patients, 8 weeks of alagebrium reduced carotid augmentation index (AI) (p=0.007) and carotid augmented pressure (p<0.001) and improved flow-mediated dilation (p<0.05). P...